Effect of fenretinide on ovarian carcinoma occurrence

Gynecologic Oncology

Volumn 86, Issue 1, 2002, Pages 24-27

  De Palo, Giuseppe ^a   Mariani, Luigi ^a   Camerini, Tiziana ^a   Marubini, Ettore ^a   Formelli, Franca ^a   Pasini, Barbara ^a   Decensi, Andrea ^b   Veronesi, Umberto ^c  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b Division of Chemoprevention   (Italy)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Fenretinide; Ovarian carcinoma

Indexed keywords

FENRETINIDE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER PREVENTION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; GERM LINE; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; ONCOGENE; OVARY CARCINOMA; PRIORITY JOURNAL; PROBABILITY; PROTECTION;

EID: 0036311173     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2002.6663     Document Type: Article

References (16)

1. Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells
2. Chemoprevention of cancer with retinoids
3. N-(4-Hydroxyphenil) retinamide, a new retinoid for prevention of breast cancer in the rat
4. Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer
5. Can fenretinide protect women against ovarian cancer?
6. Chemoprevention trial of contralateral breast cancer with fenretinide. Rationale, design, methodology, organization, data management, statistics and accrual
7. Staging announcement
8. Determining carrier probability for breast cancer susceptibility genes BRCA1 and BRCA2
9. Synthetic retinoid fenretinide is effective against a human ovarian carcinoma xenograft and potentiates cisplatin activity
10. Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression
11. Retinoic acid receptor beta expression and growth inhibition of gynecologic cancer cells by the synthetic retinoid N-(4-hydroxyphenil)retinamide
12. Growth-inhibitory effects of the synthetic retinoid CD437 against ovarian carcinoma models in vitro and in vivo
13. Effects of retinoids on cancerous phenotype and apoptosis in organotypic cultures of ovarian carcinoma
14. Fenretinide (4-HPR) in chemoprevention of oral leukoplakia
15. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin